Private Equity

A new partnership brings institutional-grade private markets data from Hamilton Lane to financial advisors, aiming to demystify alternative investments.

A 79-unit building sale in St. Catharines marks a new investor's arrival, highlighting a trend targeting Southwestern Ontario's rental markets.

A new lawsuit claims private equity giant TPG hid implant defects and forced a bankruptcy, leaving thousands of injured patients to pay the price.

A new survey shows most family firms expect a leadership change soon, but few are prepared, creating a high-stakes gap between intent and action.

In a major market shakeup, Dingdong is selling its China grocery operations to rival Meituan and plans to return the proceeds to shareholders.

Lithuanian manufacturer Eurodita's 'no minimum order' private-label plan could reshape Europe's construction market for independent dealers.

DFR Gold secures $1.2M in insider loans, pushing total debt to $4.5M. The funds aim to fast-track its Burkina Faso gold project, but is it a vote of confidence or a sign of financial strain?

A Canadian family-owned food manufacturer expands with a new facility and pasta line, capitalizing on the booming demand for ready-to-eat ingredients.

The advanced nuclear startup's new funding and partnership with Blue Owl signal a major push to solve the massive energy demands of data centers.

FPX Nickel's massive Baptiste project could supply low-carbon nickel for EVs, but it first needs to win over the public and regulators. Here's what's at stake.

The advisory giant's acquisition of a Boston-based specialist signals a strategic push into the high-stakes, high-growth world of life sciences and biotech.

With a new CEO from the plaintiff legal world, Practice Made Perfect aims to scale its unique model for law firm growth in an increasingly competitive market.

A new partnership between South Korea's GCCL and Europe's Medicover MICS promises to streamline drug development by creating a seamless East-West axis.

Following a landmark FDA approval, IceCure Medical's long-serving CFO is exiting, placing the company at a pivotal financial crossroads for its new treatment.

The BDC generated a robust 12.52% yield, but a $7.2M unrealized loss in equities pulled down its net asset value, painting a complex picture.

With its IPO complete, Cambridge Acquisition Corp. enters a disciplined SPAC market with a clear focus on wellness, hemp, and psychedelic tech targets.

Belgian biotech Agomab Therapeutics secures $200 million in its Nasdaq debut, fueling its mission to develop therapies for debilitating fibrotic conditions.

As Nordstrom marks 125 years, its year-long celebration is more than a party—it's a strategic move to bolster loyalty and adapt in a tough market.

Honda's landmark partnership with the iconic 6666 Ranch goes beyond branding, testing its rugged vehicles in the heart of authentic American ranching.

The era of rapid, uniform skyscraper growth is over. A new report reveals a global shift to selective development amid economic and geopolitical pressures.